Diagnosis and treatment guideline for Chinese Medicine on non-alcoholic steatohepatitis

Branch of Hepatobiliary Diseases, China Association of Chinese Medicine

doi:10.3969/j.issn.1001-5256.2023.05.007

Volume 39 Issue 5

May 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(5): 1041-1048

PDF( 1893 KB)

Diagnosis and treatment guideline for Chinese Medicine on non-alcoholic steatohepatitis

DOI: 10.3969/j.issn.1001-5256.2023.05.007

Branch of Hepatobiliary Diseases, China Association of Chinese Medicine^,

Research funding:

National Famous TCM Doctor Studio Construction (Guozhongyiyao Renjiaohan [2022] No. 245);

The Second Batch of Discipline Construction Project of Traditional Chinese Medicine in Henan Province (STG-ZYX03-202120)

Received Date: 2023-03-06
Accepted Date: 2023-03-29
Published Date: 2023-05-20

Abstract

- Non-alcoholic Fatty Liver Disease,
- Traditional Chinese Medicine,
- Diagnosis,
- Therapeutics,
- Practice Guideline

Corresponding author： ZHAO Wenxia, zhao-wenxia@163.com (ORCID: 0000-0001-6666-9469)

FullText(HTML)

References(34)

References

[1]	CHALASANI N, YOUNOSSI Z, LAVINE JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 67(1): 328-357. DOI: 10.1002/hep.29367.
[2]	National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007. 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
[3]	ESTES C, ANSTEE QM, ARIAS-LOSTE MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol, 2018, 69(4): 896-904. DOI: 10.1016/j.jhep.2018.05.036.
[4]	BRAILLON A. Nonalcoholic steatohepatitisand hepatocellular carcinoma: crying wolfor promoting healthy living?[J]. Clin Gastroenterol Hepatol, 2019, 27(11): 2383. DOI: 10.1016/j.cgh.2019.04.029.
[5]	WANG YY, CHEN YL, WANG XQ, et al. Development and revision of clinical practice guideline of traditional medicine/integrated traditional and western medicine: Constitution of guideline development group and its workflow[J]. China J Tradit Chin Med Pharma, 2016, 31(4): 1313-1315. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201604052.htm 王洋洋, 陈耀龙, 王小琴, 等. 中医(中西医结合)临床实践指南制修订方法: 指南小组的形成与工作流程[J]. 中华中医药杂志, 2016, 31(4): 1313-1315. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201604052.htm
[6]	China Association of Traditional Chinese Medicine. General rules of preparation of diagnosis and treatment guideline in Traditional Chinese Medicine[S]. Beijing: China Press of Traditional Chinese Medicine, 2015. 中华中药学会. 中医临床诊疗指南编制通则[S]. 北京: 中国中医药出版社, 2015.
[7]	CHEN W, FANG SN, LIU JP. Recommendations for clinical evidence grading on Traditional Chinese Medicine based on evidence body[J]. Chin J Integr Trad West Med, 2019, 39(3): 358-364. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201903021.htm 陈薇, 方赛男, 刘建平. 基于证据体的中医药临床证据分级标准建议[J]. 中国中西医结合杂志, 2019, 39(3): 358-364. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201903021.htm
[8]	YANG SH, CHEN KJ, LIU JP, et al. Criterion and Detailed Judgments for the Transformation from Evidence to Recommendations in the Clinical Practice Guidelines of Chinese Medicine[J]. Chin J Integr Trad West Med, 2021, 41(4): 494-498. DOI: 10.7661/j.cjim.20210228.020. 杨思红, 陈可冀, 刘建平, 等. 中医药临床实践指南从证据到推荐意见形成要目和解读[J]. 中国中西医结合杂志, 2021, 41(4): 494-498. DOI: 10.7661/j.cjim.20210228.020.
[9]	The Chinese National Work-shop on Fatty Liver and Alcoholic Live Disease for the Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Chin J Gastroenterol Hepatol, 2010, 19(6): 483-487. DOI: 10.3969/j.issn.1006-5709.2010.06.001. 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 胃肠病学和肝病学杂志, 2010, 19(6): 483-487. DOI: 10.3969/j.issn.1006-5709.2010.06.001.
[10]	REN WD, CHANG C. Ultrasound diagnostics[M]. Beijing: People's Health Publishing House, 2013: 228. 任卫东, 常才. 超声诊断学[M]. 北京: 人民卫生出版社, 2013: 228.
[11]	GUO CP. Application of liver-spleen CT value analysis in nonalcoholic fatty liver disease[J]. Med Philosophy, 2011, 32(7): 38-46. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZL201107014.htm 郭春朴. 肝脾CT值分析在非酒精性脂肪肝诊断中的应用[J]. 医学与哲学, 2011, 32(7): 38-46. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZL201107014.htm
[12]	ZHOU W, CHEN XQ, ZHOU YY, et al. Quantitative measurement of whole Liver fat with MR Dixon Technology: compared with liver biopsy[J]. J Med Imaging, 2018, 28(5): 775-780. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXZ201805025.htm 周围, 陈晓巧, 周园园, 等. 磁共振Dixon技术全肝脂肪定量与肝穿刺活检结果比较[J]. 医学影像学杂志, 2018, 28(5): 775-780. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXZ201805025.htm
[13]	BOHTE AE, van WERVEN JR, BIPAT S, et al. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis[J]. Eur Radiol, 2011, 21(1): 87-97. DOI: 10.1007/s00330-010-1905-5.
[14]	BEDOSSA P, POITOU C, VEYRIE N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients[J]. Hepatology, 2012, 56(5): 1751-1759. DOI: 10.1002/hep.25889.
[15]	BEDOSSA P, FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease[J]. Hepatology, 2014, 60(2): 565-575. DOI: 10.1002/hep.27173.
[16]	SHEN F, ZHENG RD, BI YQ, et al. Value of a two-step approach with cytokeratin-18 and controlled attenuation parameter in noninvasive differential diagnosis of nonalcoholic steatohepatitis[J]. Chin J Hepatol, 2016, 24(6): 429-434. DOI: 10.3760/cma.j.issn.1007-3418.2016.06.007. 沈峰, 郑瑞丹, 宓余强, 等. 细胞角蛋白-18联合受控衰减参数二步法无创鉴别非酒精性脂肪性肝炎的临床研究[J]. 中华肝脏病杂志, 2016, 24(6): 429-434. DOI: 10.3760/cma.j.issn.1007-3418.2016.06.007.
[17]	LIU XL, FAN JG. The research progress and prospects on non-alcoholic fatty liver disease[J]. J Mod Med Health, 2017, 33(5): 641-644. DOI: 10.3969/j.issn.1009-5519.2017.05.001. 刘晓琳, 范建高. 非酒精性脂肪性肝病的研究进展与展望[J]. 现代医药卫生, 2017, 33(5): 641-644. DOI: 10.3969/j.issn.1009-5519.2017.05.001.
[18]	Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease (2017)[J]. J Clin Hepatol, 2017, 33(12): 2270-2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002. 中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J]. 临床肝胆病杂志, 2017, 33(12): 2270-2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002.
[19]	ZHAO WX, ZHANG LH. The concept of non-alcoholic fatty liver disease attributing to fatty liver[J]. Henan Tradit Chin Med, 2015, 35(8): 1820-1822. DOI: 10.16367/j.issn.1003-5028.2015.08.0766. 赵文霞, 张丽慧. 非酒精性脂肪性肝病应归属"肝癖"论[J]. 河南中医, 2015, 35(8): 1820-1822. DOI: 10.16367/j.issn.1003-5028.2015.08.0766.
[20]	ZHANG BL, XUE BY. Internal medicine of Traditional Chinese Medicine[M]. Beijing: People's Medical Publishing House, 2012: 216-217. 张伯礼, 薛博瑜. 中医内科学[M]. 北京: 人民卫生出版社, 2012: 216-217.
[21]	Diagnosis and Treatment Center of Hepatology of South China Alliance of TCM, National Administration of Traditional Chinese Medicine. Diagnosis and treatment scheme of Ganpi (non-alcoholic steatohepatitis)[J/CD]. Chin J Liver Dis (Electronic Version), 2021, 13(1): 1-9. DOI: 10.3969/j.issn.1674-7380.2021.01.001. 国家中医药管理局华南区中医肝病诊疗中心联盟. 肝癖(非酒精性脂肪性肝炎)诊疗方案[J/CD]. 中国肝脏病杂志(电子版), 2021, 13(1): 1-9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.
[22]	ZHANG YN, FAN ZP. Efficacy and safety evaluation of exercise prescription in the treatment ofpatients with nonalcoholic fatty liver disease[J]. J Prac Hepatol, 2020, 23(3): 360-363. DOI: 10.3969/j.issn.1672-5069.2020.03.015. 张亚男, 范竹萍. 运动处方应用于非酒精性脂肪性肝病患者治疗作用和安全性评价[J]. 实用肝脏病杂志, 2020, 23(3): 360-363. DOI: 10.3969/j.issn.1672-5069.2020.03.015.
[23]	ZHAO WX, LIU QZ, LIU JY, et al. Clinical observation of Huatan Lishi Houxue formula for 96 patients with non-alcoholic steatohepatitis[J]. J Tradit Chin Med, 2012, 53(12): 1025-1027. 赵文霞, 刘全忠, 刘君颖, 等. 化痰利湿活血方加减治疗非酒精性脂肪性肝炎患者96例临床观察[J]. 中医杂志, 2012, 53(12): 1025-1027.
[24]	PEI Q, WANG XS, WANG XB, et al. Clinical study of Qinggan Huatan Huoxue Recipe on the treatment of non-alcoholic steatohepatitis[J]. Chin J Integr Trad West Med, 2012, 32(1): 29-31. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201201011.htm 裴强, 王晓素, 王宪波, 等. 清肝化痰活血方治疗非酒精性脂肪性肝炎的临床研究[J]. 中国中西医结合杂志, 2012, 32(1): 29-31. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201201011.htm
[25]	LAN XM, WU YN, CHEN SD, et al. Treatment of nonalcoholic steatohepatitis by Zaozhu Yinchen recipe[J]. Chin J Integr Trad West Med, 2019, 39(5): 557-560. DOI: 10.7661/j.cjim.20190125.099. 兰秀梅, 吴耀南, 陈少东, 等. 皂术茵陈方治疗非酒精性脂肪性肝炎的临床观察[J]. 中国中西医结合杂志, 2019, 39(5): 557-560. DOI: 10.7661/j.cjim.20190125.099.
[26]	LI ZM, GONG M, LI MQ, et al. Clinical study on Dangfei Liganning capsule for nonalcoholic simple fatty liver disease: a report on 113 cases[J]. J Tradit Chin Med, 2012, 53(1): 38-41. 李朝敏, 龚枚, 李明权, 等. 当飞利肝宁胶囊治疗非酒精性单纯性脂肪肝患者113例临床研究[J]. 中医杂志, 2012, 53(1): 38-41.
[27]	WU J, PENG YZ. Efficacy of Dangfeiliganning capsule in nonalcoholic fatty liver disease[J]. Pract Clin Med, 2018, 19(6): 4-6. DOI: 10.13764/j.cnki.lcsy.2018.06.002. 武敬, 彭雁忠. 当飞利肝宁胶囊治疗非酒精性单纯性脂肪肝的效果[J]. 实用临床医学, 2018, 19(6): 4-6. DOI: 10.13764/j.cnki.lcsy.2018.06.002.
[28]	JIANG YY, LIN J, DONG PL, et al. Treatment of non-alcoholic steatohepatitis by Dahuang Lidan capsule[J]. Chin J Integr Trad West Med, 2017, 37(5): 539-542. DOI: 10.7661/j.cjim.20170315.037. 江宇泳, 林静, 董培玲, 等. 大黄利胆胶囊治疗非酒精性脂肪性肝炎的临床研究[J]. 中国中西医结合杂志, 2017, 37(5): 539-542. DOI: 10.7661/j.cjim.20170315.037.
[29]	WANG ZY, LI ZJ. Effect of Dahuang Lidan tablets on serum IL-1 RA, IL-1β, IL-18 levels and intestinal flora in patients with non-alcoholic fatty liver disease in damp-heat accumulation pattern[J]. J Nangjing Univ Tradit Chin Med, 2020, 36(5): 762-766. DOI: 10.14148/j.issn.1672-0482.2020.0762. 王争艳, 李正军. 大黄利胆片对非酒精性脂肪性肝病湿热蕴结证患者血清IL-1RA、IL-1β、IL-18水平和肠道菌群的影响[J]. 南京中医药大学学报, 2020, 36(5): 762-766. DOI: 10.14148/j.issn.1672-0482.2020.0762.
[30]	LIU LL, MAO DW, LYU JL, et al. Meta analysis of efficacy and safety of Qianggan Capsules on patients with nonalcoholic fatty liver disease[J]. Chin Tradit Patent Med, 2018, 40(8): 1715-1720. DOI: 10.3969/j.issn.1001-1528.2018.08.009. 柳琳琳, 毛德文, 吕建林, 等. 强肝胶囊对非酒精性脂肪性肝病患者疗效及安全性的Meta分析[J]. 中成药, 2018, 40(8): 1715-1720. DOI: 10.3969/j.issn.1001-1528.2018.08.009.
[31]	LU YJ, HUANG B, ZHANG HX. Meta-analysis of the efficacy of acupoint catgut embedding in the treatment of nonalcoholic fatty liver disease[J]. Guangxi J Tradit Chin Med, 2021, 44(4): 36-43. DOI: 10.3969/j.issn.1003-0719.2021.04.014. 陆英俊, 黄彬, 张红星. 穴位埋线治疗非酒精性脂肪肝疗效的Meta分析[J]. 广西中医药, 2021, 44(4): 36-43. DOI: 10.3969/j.issn.1003-0719.2021.04.014.
[32]	HUANG Z, SONG S, TAN K, et al. Observation on clinical effects of acupoint thread-embedding method for non-alcoholic fatty liver disease[J]. J Acupunct Tuina Sci, 2016, 14 (3): 186-191. DOI: 10.1007/s11726-016-0922-6.
[33]	General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Standardization Administration of China. GB/T 21709.10-2008 Standardized manipulations of acupuncture and moxibustion-part 10: acupoint paste[S]. Beijing: Standards Press of China, 2008. 中华人民共和国国家质量监督检验检疫总局, 中国国家标准化管理委员会. GB/T 21709.10-2008针灸技术操作规范第10部分: 穴位埋线[S]. 北京: 中国标准出版社, 2008.
[34]	China Association of Chinese Medicine. T/CACM024- 2017 Guide of Chinese clinic pactice: acupoint embedding treatment for weight-losing[S]. http://www.ttbz.org.cn/StandardManage/Detail/26145/. 中华中医药学会. T/CACM024-2017中医临床实践指南穴位埋线减肥[S]. http://www.ttbz.org.cn/StandardManage/Detail/26145/.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1239) PDF downloads(449)

Diagnosis and treatment guideline for Chinese Medicine on non-alcoholic steatohepatitis

DOI: 10.3969/j.issn.1001-5256.2023.05.007

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Diagnosis and treatment guideline for Chinese Medicine on non-alcoholic steatohepatitis

DOI: 10.3969/j.issn.1001-5256.2023.05.007

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content